Aa
Aa
A
A
A
Close
Avatar universal

Is Depakine (valproid acid) good or bad for children with Attention Deficit?

I am a happy father of 2 boys. My older son (now 8.5 yrs) had his first seizure 18 month ago and a second one 1 month ago. Despite the low frequency, due to long duration (~1hr! in both cases) the doctor suggested to start medication and suggested depakine (valproid acid) mentioning it could potentially help with the attention deficit problem (ADD / ADHD).
To be sure, I checked with another doctor and to my surprise she said that depakine could deteriorate the attention deficit issue, based on recent research and publications, therefore she suggested keppra (levetiracetam).
Can anyone help so as to take a decision on the medication?
Thanks a lot in advance!
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
Thanks Caregiver222. I found quite a few relevant studies there.

Any other view and personal experience would help.

Thanks!
Helpful - 0
144586 tn?1284666164
The use of medications to treat siezures is controversial - all have side effects. The evidence-based answers you seek can be found on the U.S. government website "Pubmed". Information on treatment protocols with these medications are available on that site.
Helpful - 0
Have an Answer?

You are reading content posted in the Neurology Community

Top Neurology Answerers
620923 tn?1452915648
Allentown, PA
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease